Is Hair Loss a Side Effect of Mounjaro?

Hair shedding linked to Mounjaro is most commonly telogen effluvium — a temporary, stress-related response to significant calorie restriction and rapid weight change, not a direct drug effect.
Tirzepatide is not listed as causing alopecia in the Mounjaro SmPC or the NHS medicines information for tirzepatide; hair loss should be reported to your prescriber so other causes can be ruled out.
Adequate protein intake, hydration and micronutrient levels matter more during active weight loss, your prescriber or a dietitian can help you protect both your results and your hair.
Any new or worsening symptom during treatment can be reported to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk, and to your prescriber directly.

Hair loss can happen during Mounjaro treatment, but it is not listed as a direct pharmacological side effect of tirzepatide itself. The most likely cause is a condition called telogen effluvium — a temporary shedding triggered by rapid weight loss rather than by the medicine. Understanding that distinction helps you decide what to do next. Mounjaro is a prescription-only medicine; a prescriber reviews every case before treatment begins and stays available throughout.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the evidence actually says about Mounjaro, weight loss and hair shedding

The decision you're probably trying to make right now

You noticed more hair in the shower drain a few weeks into treatment (or a friend warned you it would happen) and now you're weighing whether Mounjaro is the cause, whether it will get worse, and whether you should stop. That worry is entirely understandable. Hair is visible; losing it feels significant. The reassuring starting point is that the pattern of hair shedding most often reported by people on GLP-1 treatments has a well-understood explanation that is not about the medicine attacking your follicles.

The key question to settle first is what kind of hair loss you are experiencing. Telogen effluvium is a temporary increase in the normal hair-shedding cycle, triggered when the body registers significant physical stress, and rapid weight loss, whatever its cause, qualifies as that kind of stress. It typically starts six to twelve weeks after the trigger and slows down as the body adjusts. It is diffuse rather than patchy, and it is reversible. That is the pattern most commonly reported by people losing weight quickly, whether through surgery, restrictive dieting or medicines like tirzepatide.

Mounjaro's SmPC and the NHS tirzepatide medicines page do not list alopecia among the recognised side effects of tirzepatide. That does not mean no one experiences it, but it does mean the evidence points to the weight loss itself, not the molecule, as the driver. Reporting it to your prescriber allows other causes (thyroid changes, iron deficiency, nutritional gaps) to be checked and ruled out.

What actually drives the shedding, and what you can do about it

Tirzepatide reduces appetite substantially. People eat less, often quite a lot less, particularly in the early months of treatment. If protein intake drops too low, or total calorie restriction is severe, the body deprioritises non-essential processes, and hair growth is one of them. Iron, zinc, biotin and B vitamins are all involved in follicle health; a diet that has shrunk significantly can fall short of all of them without obvious signs elsewhere.

This does not mean you need to eat more than is comfortable or abandon the calorie reduction that makes treatment work. It means the quality and composition of what you do eat matters more, not less. Prioritising protein at each meal, staying well hydrated and taking a broad-spectrum multivitamin are practical steps many prescribers suggest. You can read more about the full side-effect profile of Mounjaro to understand which effects are direct and which are downstream of the weight loss itself.

For most people, shedding slows and stops as weight loss stabilises. Regrowth follows. The hair that comes back is normal hair. That timeline (roughly three to six months from peak shed to visible recovery) is consistent with how telogen effluvium resolves regardless of its trigger. If you want a closer look at how Mounjaro hair loss unfolds over the course of treatment, including what the recovery phase typically looks like, that page brings together the key details. It is worth noting that some people on Mounjaro report unexpected positive side effects alongside temporary ones like this.

When to seek medical help

Most hair shedding during Mounjaro treatment does not need urgent attention, but some situations do. Tell your prescriber promptly if your hair loss is patchy rather than diffuse, if it is accelerating beyond the first few months, or if you notice other new symptoms at the same time (fatigue, cold intolerance, brittle nails) which can point to thyroid or nutritional issues that need testing.

Separately, Mounjaro carries some side effects that do warrant urgent care. Severe, persistent stomach pain that radiates to the back (with or without vomiting) may indicate acute pancreatitis, and the MHRA highlighted this risk in a Drug Safety Update for GLP-1 medicines. Get medical help the same day if that happens. Signs of a serious allergic reaction (swelling of the face or throat, difficulty breathing), gallbladder symptoms (sharp pain in the upper right abdomen), or symptoms of severe dehydration following persistent sickness or diarrhoea should also prompt immediate contact with a healthcare professional. The MHRA Yellow Card scheme lets you report any suspected side effect directly, including hair loss, which helps build the national evidence base.

If you are concerned about any symptom you have noticed on tirzepatide, our support team is available seven days a week and your prescriber can review your case.

Hair loss in context: is Mounjaro still the right choice?

For most people, temporary hair shedding does not outweigh the health benefits of sustained weight loss, reduced blood pressure, improved blood sugar regulation, better joint load, lower cardiovascular risk. Those are the outcomes the NICE appraisal of tirzepatide (TA1026) weighed when recommending it. If you are still asking whether losing hair is truly a side effect of Mounjaro or a consequence of the weight loss process, that question is worth exploring before drawing conclusions. Hair that sheds during rapid weight loss generally grows back. The conditions that obesity worsens over years are harder to reverse.

That said, you are the one experiencing the side effect, and your comfort with the balance matters. This is exactly the kind of conversation our prescribers have with patients during treatment. If you have not yet started and are weighing up whether Mounjaro suits your situation, or if you are already on treatment and want to discuss what you are noticing, checking eligibility through a free consultation is the straightforward next step. A clinician reviews your answers personally (not a form-processing system) and can address questions like this directly. You can also find a detailed breakdown of Mounjaro side effects and hair loss, covering what the evidence shows and how to manage it.

For a fuller picture of what tirzepatide involves from the start, the Mounjaro treatment overview covers how it works, what to expect and how the prescription process runs. Check your eligibility to speak with our prescribers about whether it is right for you.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions